scispace - formally typeset
H

Heeyeong Cho

Researcher at Korea University of Science and Technology

Publications -  40
Citations -  676

Heeyeong Cho is an academic researcher from Korea University of Science and Technology. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 12, co-authored 34 publications receiving 567 citations. Previous affiliations of Heeyeong Cho include Samsung.

Papers
More filters
Journal ArticleDOI

Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives

TL;DR: Evidence is presented that several chrysin derivatives modulate the activities, as well as the expression, of COX-2 and iNOS enzymes, and that a hydrogen bond exists between the oxygen of the ketone group at the 7-position of Ch-4 and the hydroxyl group of Tyr355.
Journal ArticleDOI

Fucoidan from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells.

TL;DR: Results indicate that fucoidan induces apoptosis of A549 human lung cancer cells through down‐regulation of p38, PI3K/Akt, and the activation of the ERK1/2 MAPK pathway.
Journal ArticleDOI

Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.

TL;DR: The findings strongly suggest that tanshindiols possess a unique anti-cancer activity whose mechanism involves the inhibition of EZH2 activity and would provide chemically valuable information for designing a new class of potent EZh2 inhibitors.
Journal ArticleDOI

KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.

TL;DR: It is suggested that KKHA-761 is a potent antipsychotic agent with combined dopamine D3 and serotonin 5-HT1A receptors modulation activity, which may further enhance its therapeutic potential for anxiety, psychotic depression, and other related disorders.
Journal ArticleDOI

Inhibition of c-Kit signaling by diosmetin isolated from Chrysanthemum morifolium

TL;DR: Results strongly suggest that C. morifolium extract and diosmetin have potential to suppress SCF-/UVB-induced melanogenesis, and could be developed as anti-pigmentation agents.